Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
American Cures Act This bill permanently funds several federal agencies and programs that perform biomedical research. The bill provides specified funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense health program, and the Department of Veterans Affairs medical and prosthetics research program. The bill exempts the funding from sequestration, which is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals. It also exempts the budgetary effects of the funding from the Statutory Pay-As-You-Go (PAYGO) Act of 2010 and the Senate PAYGO rule.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2026 · second_quarter · Health Issues
Read twice and referred to the Committee on Appropriations. (text: CR S2239)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
S. 4494, the American Cures Act, All provisions.
Client expense: $120,000 · Firm income: Not reported
Government targets: SENATE
2026 · third_quarter · Health Issues
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; implementation of Sec. 6501 of P.L. 119-75, Preventing Maternal Deaths Reauthorization Act; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 7973, Momnibus Act H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9090/S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act; H.R. 10600, Abortion is Health Care Everywhere Act; S. ____, Know Your Risk Act; S. 3254/H.R. 6238, NIH IMPROVE Act; H.R. 9946, Equity in STI Testing Act; H.R. 3387, No Surprise Bills for New Moms Act; H.R. 9842, State Offices of Womens Health Support and Expansion Act; H.R. 2028/S. 942, REDI Act; H.R. 5536, HEADACHE Act; H.Res.739/S.Res.401, National Stillbirth Prevention & Awareness Day Resolution; S. ____, Jeanette Acosta Invest in Womens Health Act; HR.____ /S. 5554, Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act; H.R. ____, Improving Access to WIC Act; H.R. ____/S. ____, Support Through Loss Act; H.R. 6468/S. 5232, Rural Residency Planning and Development Act; H.R. _____/S. 4445, Right to IVF Act; S. 4494, maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); inclusion of pregnant and lactating women in clinical trials (general); NIH/NICHD womens health research (general); clinical research workforce development (general); access to fertility services and treatments (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); OMB Regulation for Federal Financial Assistance (OMB-2026-0034-0001); estradiol patch shortage (general); menopause education (general); risk-reducing salpingectomy (general).
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Science/Technology
FY 2027 Agriculture Appropriations bills HR 8646 - all provisions related to the National Institute of Food and Agriculture, Agriculture and Food Research Initiative FY 2027 Commerce Justice Science Appropriations bills HR 8845 - all provisions related to Department of Energy Office of Science FY 2027 Energy-Water Appropriations bills (HR 9022) - all provisions related to the Department of Energy Office of Science American Cures Act S4494 FY 2027 Senate Labor-HHS-ED appropriations bill Improving Mentorship in STEM Higher Education Act HR 9177 Agriculture Research, Education and economic reorganization Oppose regulations for federal financial assistance legislative action (91 Fed Reg 32198(a)) Support use of animal models for research Support American Science Acceleration Project Support HR 8500 Continuing Appropriations and Extensions Act 2027
Client expense: $64,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Medical/Disease Research/Clinical Labs
HR 6500, the Continuing Appropriations and Extensions Act, 2027; HR 7173, Follow the Science Act; HR 9495, FY2027 appropriations for DOD, specifically provisions related to medical research; HR 9260, FY2027 appropriations for HHS, specifically provisions related to medical research; HR 9632, Accelerating Innovation (AI) for Kids with Cancer Act; S 4494, American Cures Act; OMB Proposed Uniform Grants Regulation; Policies to enable international collaboration by NIH grantees; Policies to maintain the NIHs incremental grant funding model;
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2026 · third_quarter · Budget/Appropriations
H.R. 9770 - FY2027 Continuing Appropriations Act; H.R. 6500 - FY2027 Continuing Appropriations and Extensions Act; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4632 - Lankford-Hassan Prevent Government Shutdowns Act of 2026; S. 4440 - Clinical Trial Modernization Act; H.R. 3521 - Clinical Trial Modernization Act; S. 4494 - America Cures Act; Issues related to funding for NIH; Issues related to funding for CDC; Issues related to funding for CMS; Issues related to funding for Alzheimer's
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
H.R. 3501, S. 1799 - a bill to amend title XVIII of the Social Security Act to direct CMS to include certain standardized tests for cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination; H.R. 5371 - FY2026 Continuing Appropriations and Extensions Act; H.R. 6799 - To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with young-onset Alzheimer's, and for other purposes; H.R. 6130, S. 3267 - ASAP Act; H.R. 9418 - Access to Innovative Treatments Act of 2026; H.R. 9495 - Department of Defense Appropriations Act, 2027; H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; S. 4494 - Durbin Cures Act; Issues related to the Affordable Care Act, Medicaid and comprehensive healthcare; Issues related to implementation of PL-119-21; Issues related to coverage for biomarker testing; H.R. 9823 - The Alzheimer's Early Detection Act
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2026 · third_quarter · Medical/Disease Research/Clinical Labs
Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. Harley Jacobsen Clinical Trial Participant Income Exemption Act, S.5127, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research. Knock Out Cancer Act (H.R. 3873, or KO Cancer Act). The will would boost National Cancer Institute funding by 25% annually for FY2026-2030 to match cancers mortality toll and direct a report on drug shortages.
Client expense: $1,790,000 · Firm income: Not reported
2026 · second_quarter · Medical/Disease Research/Clinical Labs
HR 9495, FY2027 appropriations for DOD, specifically provisions related to medical research; HR 9260, FY2027 appropriations for HHS, specifically provisions related to medical research; HR 7173, Follow the Science Act; S 4494, American Cures Act; HR 9632, Accelerating Innovation (AI) for Kids with Cancer Act; OMB Proposed Uniform Grants Regulation; Policies to enable international collaboration by NIH grantees; Policies to maintain the NIHs incremental grant funding model;
Client expense: $590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Science/Technology
FY 2027 Agriculture Appropriations bills - all provisions related to the National Institute of Food and Agriculture, Agriculture and Food Research Initiative FY 2027 Commerce Justice Science Appropriations bills HR 5342 and S. 2587 - all provisions related to Department of Energy Office of Science FY 2027 Energy-Water Appropriations bills - all provisions related to the Department of Energy Office of Science American Cures Act S4494 FY 2027 Senate Labor-HHS-ED appropriations bill Improving Mentorship in STEM Higher Education Act HR 9177
Client expense: $89,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; implementation of Sec. 6501 of P.L. 119-75, Preventing Maternal Deaths Reauthorization Act; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 7973, Momnibus Act; H.R. 7830, WELLS Act; H.R.8159, Gynecologic Pain Management Study Act; H.R.8160, Premenstrual Dysphoric Disorder Awareness and Research Act; H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9061, PREEMPT Act; H.Res. 1282, a resolution recognizing ACOGs 75th anniversary; H.R. 8358, Breast Cancer Research Stamp Reauthorization Act; S. Res. 710, a resolution recognizing Maternal Mental Health Day; H.R. 9090/S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act; H.Res. 1323, a resolution recognizing National Menstrual Health Awareness Month; H.R. 8500, Timely Access to Coverage Decisions Act; H.R. 7694, Gwenns Law; S. 4878, Reproductive Health Care Training Act; H.R. _____/S. _____, Right to IVF Act; S. 4494, America Cures Act; maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); inclusion of pregnant and lactating women in clinical trials (general); pregnancy exposure registries (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); Restorative Reproductive Medicine (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); S. 4550/H.R. 8807, Maternal Health Pandemic Response Act; United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); FACE Act implementation; Nexplanon REMS; chaperones during sensitive procedures (general); FDA regulation of flavored e-cigarettes (general); ORR policies regarding pregnant minors (general); breast cancer risk assessment (general).
2026 · second_quarter · Health Issues
S. 4494, the American Cures Act, All provisions.
Client expense: $50,000 · Firm income: Not reported
Government targets: SENATE
2026 · second_quarter · Medical/Disease Research/Clinical Labs
Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Asal Sayas National Strategy on Young Adult Cancers Act, S. 4717: Directs the NIH to develop a comprehensive national strategy to address the alarming rise of cancers in adults ages 18 to 49. American Cures Act, S. 4494. This bill would permanently fund several federal agencies and programs that perform biomedical research.
Client expense: $1,240,000 · Firm income: Not reported
| Democratic |
| IL |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $96,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE